Eli Lilly and Company

News

NVIDIA announces Lilly, Thermo Fisher collaborations at JPM

Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, including a billion dollar partnership with Eli Lilly.

Market Access

Capping the cost of insulin: altruistic or strategic?

The price of insulin has become one of the most talked about issues across the pharma industry.

News

Lilly shares disappointing A4 study results for solanezumab

The drug only targets soluble amyloid beta-protein and doesn't clear amyloid plaques.

News

Lilly slashes insulin price 70%, patient cost cap now $35

Lilly trying to make it easier for patients to access its insulin and help Americans generally.

R&D

Almirall/Lilly lebrikizumab offers potential long-term manag...

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable

NVIDIA announces Lilly, Thermo Fisher collaborations at JPM

Capping the cost of insulin: altruistic or strategic?

Lilly shares disappointing A4 study results for solanezumab

Lilly slashes insulin price 70%, patient cost cap now $35

Almirall/Lilly lebrikizumab offers potential long-term manag...

After setback, Rhythm gets good news on Imcivree from FDA

Using AI-driven synthetic personas to take your insights fur...

Eli Lilly and Company

Editor's Picks